nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Felbamate—GRIN2A—melanoma	0.0542	0.518	CrCbGaD
Methocarbamol—Trauma—Bleomycin—melanoma	0.0478	0.0534	CcSEcCtD
Methocarbamol—Carvedilol—HIF1A—melanoma	0.0318	0.304	CrCbGaD
Methocarbamol—Coordination abnormal—Carmustine—melanoma	0.0202	0.0226	CcSEcCtD
Methocarbamol—Coordination abnormal—Temozolomide—melanoma	0.0196	0.0218	CcSEcCtD
Methocarbamol—Injury—Bleomycin—melanoma	0.018	0.0201	CcSEcCtD
Methocarbamol—Thrombophlebitis—Carmustine—melanoma	0.0167	0.0186	CcSEcCtD
Methocarbamol—Thrombophlebitis—Temozolomide—melanoma	0.0161	0.018	CcSEcCtD
Methocarbamol—Dysgeusia—Vemurafenib—melanoma	0.0161	0.018	CcSEcCtD
Methocarbamol—Injury—Carmustine—melanoma	0.0157	0.0175	CcSEcCtD
Methocarbamol—Amnesia—Carmustine—melanoma	0.0154	0.0171	CcSEcCtD
Methocarbamol—Nasal congestion—Temozolomide—melanoma	0.0153	0.0171	CcSEcCtD
Methocarbamol—Amnesia—Temozolomide—melanoma	0.0148	0.0166	CcSEcCtD
Methocarbamol—Diplopia—Carmustine—melanoma	0.0144	0.0161	CcSEcCtD
Methocarbamol—Diplopia—Temozolomide—melanoma	0.0139	0.0156	CcSEcCtD
Methocarbamol—Anaphylactic shock—Vemurafenib—melanoma	0.0134	0.015	CcSEcCtD
Methocarbamol—Carvedilol—VEGFA—melanoma	0.0128	0.122	CrCbGaD
Methocarbamol—Hypotension—Vemurafenib—melanoma	0.0125	0.014	CcSEcCtD
Methocarbamol—Lightheadedness—Docetaxel—melanoma	0.0114	0.0128	CcSEcCtD
Methocarbamol—Thrombophlebitis—Docetaxel—melanoma	0.0107	0.012	CcSEcCtD
Methocarbamol—Flushing—Bleomycin—melanoma	0.0106	0.0118	CcSEcCtD
Methocarbamol—Body temperature increased—Vemurafenib—melanoma	0.0106	0.0118	CcSEcCtD
Methocarbamol—Flushing—Dactinomycin—melanoma	0.0099	0.0111	CcSEcCtD
Methocarbamol—Hypersensitivity—Vemurafenib—melanoma	0.00988	0.011	CcSEcCtD
Methocarbamol—Pruritus—Vemurafenib—melanoma	0.00948	0.0106	CcSEcCtD
Methocarbamol—Flushing—Carmustine—melanoma	0.00926	0.0103	CcSEcCtD
Methocarbamol—Flushing—Temozolomide—melanoma	0.00895	0.00999	CcSEcCtD
Methocarbamol—Leukopenia—Bleomycin—melanoma	0.00891	0.00995	CcSEcCtD
Methocarbamol—Dizziness—Vemurafenib—melanoma	0.00886	0.0099	CcSEcCtD
Methocarbamol—Vomiting—Vemurafenib—melanoma	0.00852	0.00952	CcSEcCtD
Methocarbamol—Rash—Vemurafenib—melanoma	0.00845	0.00944	CcSEcCtD
Methocarbamol—Dermatitis—Vemurafenib—melanoma	0.00844	0.00943	CcSEcCtD
Methocarbamol—Headache—Vemurafenib—melanoma	0.0084	0.00938	CcSEcCtD
Methocarbamol—Leukopenia—Dactinomycin—melanoma	0.00831	0.00928	CcSEcCtD
Methocarbamol—Dysgeusia—Temozolomide—melanoma	0.00822	0.00918	CcSEcCtD
Methocarbamol—Confusional state—Bleomycin—melanoma	0.00819	0.00915	CcSEcCtD
Methocarbamol—Vision blurred—Carmustine—melanoma	0.00819	0.00914	CcSEcCtD
Methocarbamol—Anaphylactic shock—Bleomycin—melanoma	0.00812	0.00907	CcSEcCtD
Methocarbamol—Nausea—Vemurafenib—melanoma	0.00796	0.00889	CcSEcCtD
Methocarbamol—Vision blurred—Temozolomide—melanoma	0.00791	0.00884	CcSEcCtD
Methocarbamol—Leukopenia—Carmustine—melanoma	0.00778	0.00868	CcSEcCtD
Methocarbamol—Angioedema—Temozolomide—melanoma	0.00767	0.00857	CcSEcCtD
Methocarbamol—Hypotension—Bleomycin—melanoma	0.00759	0.00848	CcSEcCtD
Methocarbamol—Vertigo—Temozolomide—melanoma	0.00754	0.00842	CcSEcCtD
Methocarbamol—Convulsion—Carmustine—melanoma	0.00753	0.00841	CcSEcCtD
Methocarbamol—Leukopenia—Temozolomide—melanoma	0.00751	0.00839	CcSEcCtD
Methocarbamol—Convulsion—Temozolomide—melanoma	0.00727	0.00812	CcSEcCtD
Methocarbamol—Confusional state—Carmustine—melanoma	0.00715	0.00798	CcSEcCtD
Methocarbamol—Jaundice—Docetaxel—melanoma	0.00696	0.00778	CcSEcCtD
Methocarbamol—Pain—Bleomycin—melanoma	0.00695	0.00776	CcSEcCtD
Methocarbamol—Conjunctivitis—Docetaxel—melanoma	0.00694	0.00775	CcSEcCtD
Methocarbamol—Confusional state—Temozolomide—melanoma	0.00691	0.00771	CcSEcCtD
Methocarbamol—Anaphylactic shock—Temozolomide—melanoma	0.00685	0.00765	CcSEcCtD
Methocarbamol—Feeling abnormal—Bleomycin—melanoma	0.00669	0.00747	CcSEcCtD
Methocarbamol—Hypotension—Carmustine—melanoma	0.00662	0.0074	CcSEcCtD
Methocarbamol—Pain—Dactinomycin—melanoma	0.00648	0.00723	CcSEcCtD
Methocarbamol—Urticaria—Bleomycin—melanoma	0.00645	0.00721	CcSEcCtD
Methocarbamol—Body temperature increased—Bleomycin—melanoma	0.00642	0.00717	CcSEcCtD
Methocarbamol—Insomnia—Carmustine—melanoma	0.00641	0.00716	CcSEcCtD
Methocarbamol—Somnolence—Carmustine—melanoma	0.0063	0.00704	CcSEcCtD
Methocarbamol—Feeling abnormal—Dactinomycin—melanoma	0.00624	0.00697	CcSEcCtD
Methocarbamol—Insomnia—Temozolomide—melanoma	0.0062	0.00692	CcSEcCtD
Methocarbamol—Somnolence—Temozolomide—melanoma	0.00609	0.0068	CcSEcCtD
Methocarbamol—Pain—Carmustine—melanoma	0.00606	0.00677	CcSEcCtD
Methocarbamol—Dyspepsia—Temozolomide—melanoma	0.00603	0.00674	CcSEcCtD
Methocarbamol—Body temperature increased—Dactinomycin—melanoma	0.00599	0.00669	CcSEcCtD
Methocarbamol—Hypersensitivity—Bleomycin—melanoma	0.00598	0.00668	CcSEcCtD
Methocarbamol—Flushing—Docetaxel—melanoma	0.00595	0.00665	CcSEcCtD
Methocarbamol—Pain—Temozolomide—melanoma	0.00586	0.00654	CcSEcCtD
Methocarbamol—Feeling abnormal—Carmustine—melanoma	0.00584	0.00652	CcSEcCtD
Methocarbamol—Pruritus—Bleomycin—melanoma	0.00575	0.00642	CcSEcCtD
Methocarbamol—Feeling abnormal—Temozolomide—melanoma	0.00565	0.00631	CcSEcCtD
Methocarbamol—Body temperature increased—Carmustine—melanoma	0.0056	0.00626	CcSEcCtD
Methocarbamol—Hypersensitivity—Dactinomycin—melanoma	0.00558	0.00623	CcSEcCtD
Methocarbamol—Dysgeusia—Docetaxel—melanoma	0.00547	0.00611	CcSEcCtD
Methocarbamol—Urticaria—Temozolomide—melanoma	0.00544	0.00608	CcSEcCtD
Methocarbamol—Body temperature increased—Temozolomide—melanoma	0.00542	0.00605	CcSEcCtD
Methocarbamol—Hypersensitivity—Carmustine—melanoma	0.00522	0.00583	CcSEcCtD
Methocarbamol—Vomiting—Bleomycin—melanoma	0.00516	0.00577	CcSEcCtD
Methocarbamol—Rash—Bleomycin—melanoma	0.00512	0.00572	CcSEcCtD
Methocarbamol—Dermatitis—Bleomycin—melanoma	0.00512	0.00571	CcSEcCtD
Methocarbamol—Hypersensitivity—Temozolomide—melanoma	0.00505	0.00564	CcSEcCtD
Methocarbamol—Syncope—Docetaxel—melanoma	0.00501	0.00559	CcSEcCtD
Methocarbamol—Leukopenia—Docetaxel—melanoma	0.005	0.00558	CcSEcCtD
Methocarbamol—Loss of consciousness—Docetaxel—melanoma	0.00491	0.00548	CcSEcCtD
Methocarbamol—Pruritus—Temozolomide—melanoma	0.00485	0.00541	CcSEcCtD
Methocarbamol—Convulsion—Docetaxel—melanoma	0.00484	0.0054	CcSEcCtD
Methocarbamol—Nausea—Bleomycin—melanoma	0.00482	0.00539	CcSEcCtD
Methocarbamol—Vomiting—Dactinomycin—melanoma	0.00482	0.00538	CcSEcCtD
Methocarbamol—Rash—Dactinomycin—melanoma	0.00478	0.00533	CcSEcCtD
Methocarbamol—Dizziness—Carmustine—melanoma	0.00469	0.00524	CcSEcCtD
Methocarbamol—Confusional state—Docetaxel—melanoma	0.00459	0.00513	CcSEcCtD
Methocarbamol—Anaphylactic shock—Docetaxel—melanoma	0.00456	0.00509	CcSEcCtD
Methocarbamol—Dizziness—Temozolomide—melanoma	0.00453	0.00506	CcSEcCtD
Methocarbamol—Vomiting—Carmustine—melanoma	0.00451	0.00503	CcSEcCtD
Methocarbamol—Nausea—Dactinomycin—melanoma	0.0045	0.00502	CcSEcCtD
Methocarbamol—Shock—Docetaxel—melanoma	0.00448	0.00501	CcSEcCtD
Methocarbamol—Rash—Carmustine—melanoma	0.00447	0.00499	CcSEcCtD
Methocarbamol—Dermatitis—Carmustine—melanoma	0.00447	0.00499	CcSEcCtD
Methocarbamol—Headache—Carmustine—melanoma	0.00444	0.00496	CcSEcCtD
Methocarbamol—Vomiting—Temozolomide—melanoma	0.00436	0.00486	CcSEcCtD
Methocarbamol—Rash—Temozolomide—melanoma	0.00432	0.00482	CcSEcCtD
Methocarbamol—Dermatitis—Temozolomide—melanoma	0.00432	0.00482	CcSEcCtD
Methocarbamol—Headache—Temozolomide—melanoma	0.00429	0.00479	CcSEcCtD
Methocarbamol—Hypotension—Docetaxel—melanoma	0.00426	0.00475	CcSEcCtD
Methocarbamol—Nausea—Carmustine—melanoma	0.00421	0.0047	CcSEcCtD
Methocarbamol—Insomnia—Docetaxel—melanoma	0.00412	0.0046	CcSEcCtD
Methocarbamol—Nausea—Temozolomide—melanoma	0.00407	0.00454	CcSEcCtD
Methocarbamol—Somnolence—Docetaxel—melanoma	0.00405	0.00452	CcSEcCtD
Methocarbamol—Dyspepsia—Docetaxel—melanoma	0.00401	0.00448	CcSEcCtD
Methocarbamol—Pain—Docetaxel—melanoma	0.0039	0.00435	CcSEcCtD
Methocarbamol—Feeling abnormal—Docetaxel—melanoma	0.00375	0.00419	CcSEcCtD
Methocarbamol—Body temperature increased—Docetaxel—melanoma	0.0036	0.00402	CcSEcCtD
Methocarbamol—Hypersensitivity—Docetaxel—melanoma	0.00336	0.00375	CcSEcCtD
Methocarbamol—Carvedilol—ABCB1—melanoma	0.00328	0.0314	CrCbGaD
Methocarbamol—Pruritus—Docetaxel—melanoma	0.00322	0.0036	CcSEcCtD
Methocarbamol—Dizziness—Docetaxel—melanoma	0.00301	0.00336	CcSEcCtD
Methocarbamol—Vomiting—Docetaxel—melanoma	0.0029	0.00324	CcSEcCtD
Methocarbamol—Rash—Docetaxel—melanoma	0.00287	0.00321	CcSEcCtD
Methocarbamol—Dermatitis—Docetaxel—melanoma	0.00287	0.00321	CcSEcCtD
Methocarbamol—Headache—Docetaxel—melanoma	0.00285	0.00319	CcSEcCtD
Methocarbamol—Nausea—Docetaxel—melanoma	0.00271	0.00302	CcSEcCtD
Methocarbamol—Propranolol—ABCB1—melanoma	0.0025	0.0239	CrCbGaD
